Nutrition firm links women’s health to longevity solutions

Two diverse women in activewear working out outdoors, promoting body positivity and health. Photo: Polina Tankilevitch/Pexels

Nutrition brands are increasingly focusing on longevity through targeted solutions rather than broad-supplement approaches. At SupplySide Global 2026, Gnosis by Lesaffre presented its portfolio as a framework for addressing specific health needs tied to aging. The company’s strategy moves beyond generic longevity messaging, instead promoting the concept of “More Life in a Lifetime.” According to Emily Harris, associate director of marketing for the Americas at Gnosis by Lesaffre, the aim is to help brands translate longevity into practical, benefit-driven products that preserve physiological capabilities over time.

The company’s portfolio emphasizes women’s health, particularly ingredients supporting fertility, pregnancy, and menopause-related challenges. Key offerings include Adonat S-adenosylmethionine (SAMe) and Quatrefolic (active folate) for brain health, MenaQ7 K2 (vitamin K2 as menaquinone-7) and Quatrefolic for cardiovascular health, and MyCondro (non-animal chondroitin sulfate) and MenaQ7 K2 for lifelong mobility and bone health. At the trade show, Gnosis showcased formulation concepts such as MyCondro soluble stick packs and MenaQ7 gummies, alongside finished products addressing longevity, women’s health, gut function, and immune support. Harris noted the company is refreshing the Adonat SAMe brand identity based on new consumer research to improve market relevance.

Women’s health drives targeted longevity solutions

The industry shift reflects a move from broad “healthy aging” claims to tailored solutions for specific life stages. Women’s health, particularly during perimenopause and menopause, has become a priority. Harris explained that during these phases, women focus on fitness, recovery, and resilience—areas where targeted nutrition plays a significant role. Postmenopause accelerates cardiometabolic changes, such as arterial stiffening, as well as bone density loss, while sleep disruption impacts cognitive function. Consumers now view health as an interconnected system, seeking products that address multiple needs rather than isolated benefits.

Gnosis by Lesaffre is positioning itself to help brands develop such integrated solutions. For example, combining Adonat SAMe and Quatrefolic supports brain health and mood, while pairing MyCondro and MenaQ7 connects joint mobility with bone health. The company also stresses the importance of convenience, noting that successful products must fit seamlessly into daily routines. While strong clinical research backs Gnosis’s ingredients, Harris emphasized that format and taste are equally critical for long-term adherence. The company offers MyCondro, a precision-fermented, non-animal chondroitin with clinical support at a lower dose than conventional animal-derived chondroitin, aligning with consumer demand for plant-based and efficient solutions.

Supply chain and formulation challenges demand innovation

The nutrition industry faces challenges in supply chain reliability, formulation complexity, and price pressures. Gnosis addresses these by providing batch consistency, smaller-dose formulations, and support across R&D, regulatory, and marketing. Harris noted that ingredient compatibility, particularly stability and sensory performance, must be carefully managed to avoid compromising efficacy. The company is also adapting to trends like gummies, softgels, and functional foods while maintaining competitive pricing. Customer support includes technical guidance, regulatory compliance, and balancing brand messaging with market-specific requirements.

The mobility sector is evolving beyond traditional joint support, with growing emphasis on maintaining fluid movement and flexibility as women age. Gnosis highlights MyCondro as a precision-fermented, non-animal chondroitin offering clinical backing at lower doses. This aligns with demand for plant-based solutions that support long-term joint health without compromising efficacy. The company’s formulation flexibility, including soluble stick packs and gummies, ensures the ingredient can be integrated into diverse product formats, from daily supplements to functional foods.

The company’s approach reflects this trend by combining ingredients like MenaQ7 with vitamin D3 and magnesium to create broader positioning for bone and heart health. Similarly, Quatrefolic and Adonat SAMe are framed as complementary solutions for brain health and mood, appealing to consumers who view wellness as a system rather than isolated benefits. Gnosis’s portfolio also includes gut and immune support, reinforcing its role in overall vitality.